E
Psyence Biomedical Ltd. PBM
$0.73 -$0.03-3.46% NASDAQ
Recommendation
Prev Close
$0.76
Volume
215,749
Avg Vol (90D)
244,356
Market Cap
$777.16K
Dividend & Yield
--
52-Week Range
$0.64 - $108.59
P/E (TTM)
--
EPS (TTM)
-$43.17
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026
1/22/2026 - Globe Newswire
Psyence Biomedical announces postponement of reverse stock split effective date
1/20/2026 - The Fly
Psyence Biomedical announces postponement of reverse stock split effective date
1/20/2026 - The Fly
Psyence Biomedical announces postponement of reverse stock split effective date
1/20/2026 - The Fly
Psyence BioMed Announces Postponement of Previously Announced Reverse Stock Split Effective Date
1/20/2026 - Globe Newswire
Psyence Biomedical Ltd trading halted, news pending
1/17/2026 - TipRanks Financial Blog
Psyence Biomedical Ltd trading halted, news pending
1/17/2026 - The Fly
Psyence Biomedical sets Jan. 20 as effective date for reverse stock split
1/15/2026 - SeekingAlpha.com: All News
Psyence Biomedical sets Jan. 20 as effective date for reverse stock split
1/15/2026 - Seeking Alpha - Healthcare
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split
1/15/2026 - Globe Newswire
Psyence BioMed Sets January 20, 2026 Start Date for 1-for-6.25 Reverse Stock Split
1/14/2026 - TipRanks Financial Blog
Psyence Biomedical approves 2026 Financial Strategy
1/12/2026 - The Fly
Psyence BioMed Approves 2026 Financial Strategy, Board Authorizes Share Buyback on Value Opportunity
1/12/2026 - Globe Newswire
Psyence Biomedical (PBM) Pioneers GMP-Grade Ibogaine Production
1/5/2026 - GuruFocus
Psyence Biomedical appoints Graham Patrick to board of directors
1/5/2026 - The Fly
Psyence Biomedical announces milestone in natural ibogaine HCl production
1/5/2026 - The Fly
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash
1/5/2026 - Globe Newswire
Psyence Biomedical Ltd. (NASDAQ:PBM) Short Interest Up 205.2% in December
12/26/2025 - Ticker Report
From Super Fibers to Super Deals: Science, Scale, and Strategic Capital Shape the Morning Tape
12/19/2025 - Globe Newswire
Psyence Biomedical (PBM) Receives Approval for Psilocybin Clinical Trial
12/19/2025 - GuruFocus
Psyence Biomedical announces approval for use of PsyLab's psilocybin product
12/19/2025 - The Fly
Psyence BioMed Announces Approval for Use of PsyLabs' Psilocybin Product in Phase IIb Clinical Trial
12/19/2025 - Globe Newswire
Psyence Biomedical CEO says 2025 was a 'turning point' for company
12/9/2025 - The Fly
Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science
12/9/2025 - Globe Newswire
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
12/1/2025 - Market Exclusive
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$4.44M
EBIT (TTM)
-$4.45M
Net Income (TTM)
-$3.70M
Balance Sheet
Total Assets (Q)
$12.81M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$943.10K
Book Value Per Share (Q)
$39.62
Cash Flow
Cash from Operations (TTM)
-$4.25M
Cash from Investing (TTM)
-$4.02M
Cash from Financing (TTM)
$13.49M
Net Change in Cash (TTM)
$5.22M
Filings
Filing Date
Thursday, November 20, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Jan 19 and 23 (est)
Price History
Loading...
Beta
2.71
7-Day Total Return
-84.99%
30-Day Total Return
-92.61%
60-Day Total Return
-96.40%
90-Day Total Return
-96.89%
Year to Date Total Return
-85.30%
1-Year Total Return
-99.14%
2-Year Total Return
-100.00%
3-Year Total Return
-100.00%
5-Year Total Return
--
52-week Low
Jan 21, 2026 - $0.64
52-week High
Jan 23, 2025 - $108.59
Valuation
Market Cap
$777.16K - Nano Cap
Enterprise Value
-$6.37M
Price/Sales (TTM)
--
Price/Book (Q)
0.02
Dividends and Shares
Shares Outstanding
237.00K
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.psyencebiomed.com
Phone Number
416 346 7764
Address
121 Richmond Street West
Toronto, ON M5H2K1
Country
Canada
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients... more
NASDAQ 01/23/2026 4:00PM Eastern Quotes delayed